US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 24.150
  • -0.230-0.94%
Close Oct 1 16:00 ET
  • 24.150
  • 0.0000.00%
Post 20:01 ET
15.34BMarket Cap19.27P/E (TTM)

Genmab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Genmab Q2 2024 Earnings Date

Currency：DKKAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.96B
5.40B
+443.43M
Beat Est.
+18.12%
+29.58%
+8.94%
EPS
1.96
2.17
+0.21
Beat Est.
-5.09%
+7.00%
+10.45%
Analyst Rating
Buy

Oct 1, 2024

Genmab Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.063B--
Nov 6, 20242024/Q3-- / 5.660B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--
Feb 14, 20242023/Q44.678B / 4.610B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.063B--
Nov 6, 20242024/Q3-- / 5.660B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--
Feb 14, 20242023/Q44.678B / 4.610B--

Unlock Free Earnings Estimates

Genmab Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 1 10:35 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 11 15:51 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 14 10:50 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 8 11:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 1, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data